0:00
17:37
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
Otros episodios de "Australian Prescriber Podcast"
No te pierdas ningún episodio de “Australian Prescriber Podcast”. Síguelo en la aplicación gratuita de GetPodcast.